< Back to previous page
Researcher
Anna Sablina
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
- See also: Anna Sablina (Flanders Institute for Biotechnology)
Affiliations
- Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Member
From1 Jan 2017 → Today - Sablina Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From16 Apr 2009 → 31 Dec 2016
Projects
11 - 20 of 20
- The ubiquitin system in RAS-driven diseaseFrom1 Apr 2018 → 31 Mar 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting radiation resistance of Head and Neck Squamous Cell CarcinomaFrom1 Oct 2017 → 30 Sep 2021Funding: Fund Recuperation Fiscal Exemption, BOF - Concerted Research Project from 1994
- Targeting long non-coding RNAs in cancer therapiesFrom3 Oct 2016 → 7 Jan 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Combining radiotherapy with DNA repair inhibitors as novel treatment strategy for head and neck cancersFrom18 Aug 2016 → 30 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of RAS ubiquitination in cancer development and progression.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project
- Unraveling carboplatin resistance mechanisms in triple negative breast cancerFrom1 Nov 2014 → 26 May 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- PP2A as a component of negative feedback loops: role in cancer developmement progression.From1 Oct 2013 → 30 Sep 2017Funding: BOF - Concerted Research Project from 1994
- Role of NRas ubiquitination in control of melanoma development and progression.From1 Oct 2013 → 22 Apr 2020Funding: FWO fellowships
- The role of protein phosphatases in DNA double-strand break repair and cancer development.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project
- The role of PTK2B kinase in the RalA signaling pathway and cancer development.From27 Sep 2010 → 30 Sep 2015Funding: FWO fellowships
Publications
1 - 10 of 50
- Targeted STAT1 therapy for LZTR1-driven peripheral nerve sheath tumor(2023)
Authors: Christopher Cawthorne, Willy Gsell, Greetje Vande Velde, Christophe Deroose, Koen Van Laere, Uwe Himmelreich, Raj Sewduth, Anna Sablina
Pages: 1386 - 1390 - TIPRL1 and its ATM‑dependent phosphorylation promote radiotherapy resistance in head and neck cancer(2023)
Authors: Célie Cokelaere, Rüveyda Dok, Emanuela Elsa Cortesi, Anna Sablina, Sandra Nuyts, Rita Derua, Veerle Janssens
- Spatial Mechano-Signaling Regulation of GTPases through Non-Degradative Ubiquitination.(2023)
Authors: Raj Sewduth, Elizabeth Jones, Anna Sablina
- The deubiquitinase OTUB1 governs lung cancer cell fitness by modulating proteostasis of OXPHOS proteins(2023)
Authors: Aidana Sheryazdanova, Anna Sablina
- A bimodal mechanism of RAS inactivation by monoubiquitination(2023)
Authors: Anna Sablina
- A bimodal mechanism of RAS inactivation by monoubiquitination(2023)
Authors: Anna Sablina
- Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding(2023)
Authors: Maxim De Schepper, Tatjana Geukens, Stefaan Soenen, Christine Desmedt, Colinda Scheele, Anna Sablina, Max Mazzone
- Editorial overview: Folding and binding(2022)
Authors: Anna Sablina
- The regulation of the protein interaction network by monoubiquitination(2022)
Authors: Anna Sablina
- PPP2R4 dysfunction promotes KRAS-mutant lung adenocarcinoma development and mediates opposite responses to MEK and mTOR inhibition(2021)
Authors: Bob Meeusen, Emanuela Elsa Cortesi, Judit Domènech Omella, Anna Sablina, Juan-Jose Ventura, Veerle Janssens
Pages: 57 - 67